Gallinamide A TFA | MedChemExpress (MCE)
Gallinamide A TFA is a linearly depositing peptide and a potent inhibitor of cathepsin L (CatL) (IC50: 17.6 pM). Gallinamide A TFA inhibits SARS-CoV-2 infection by inhibiting CatL (EC50: 28 nM). Gallinamide A TFA also inhibits Plasmodium falciparum (IC50: 50 nM)[1][2].
| Trivial name | Gallinamide A TFA |
| Catalog Number | HY-N10109A |
| Research Area | Infection |
| CAS# | 1352920-57-0 |
| Purity | 99.9% |
| SMILES | CC[C@H](C)[C@H](N(C)C)C(O[C@@H](CC(C)C)C(N[C@@H](CC(C)C)C(N[C@@H](C)/C=C/C(N1[C@H](C(OC)=CC1=O)C)=O)=O)=O)=O.OC(C(F)(F)F)=O |
| Size | 25 mg |
| Supplier Page | https://www.medchemexpress.com/gallinamide-a-tfa.html |